Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors

American Journal of Roentgenology

Volumn 194, Issue 5, 2010, Pages 1250-1256

  Sharma, Amita ^a   Digumarthy, Subba R ^a   Kalra, Mannudeep K ^a   Lanuti, Michael ^a   Shepard, Jo Anne O ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CT; Lung cancer; Lung tumors; Lymphadenopathy; Radiofrequency ablation; Reactive lymph node enlargement

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADENOID CYSTIC CARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE NECROSIS; BRONCHOPLEURAL FISTULA; CANCER LOCALIZATION; CANCER SIZE; CLINICAL ARTICLE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; FISHER EXACT TEST; FOLLOW UP; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG CAVITATION; LUNG LESION; LUNG LOBE; LUNG SARCOMA; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; LYMPHADENOPATHY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDIASTINUM LYMPH NODE; MEDICAL RECORD REVIEW; MELANOMA; METASTASIS; NEUROECTODERM TUMOR; PLEURA EFFUSION; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOLOGIST; RETROSPECTIVE STUDY; RIB NECROSIS; SARCOMA; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC DISEASES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77951952729     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.09.3206     Document Type: Article

References (35)

1. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243:268-275 (Pubitemid 46579719)
2. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9:621-628
3. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137:160-166
4. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995; 2:399-404
5. Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3:212-218
6. Clasen S, Krober SM, Kosan B, et al. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer 2008; 113:3121-3129
7. Yamamoto A, Nakamura K, Matsuoka T, et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. AJR 2005; 185:1299-1306
8. Tominaga J, Miyachi H, Takase K, et al. Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: preliminary experimental study. J Vasc Interv Radiol 2005; 16:1719-1726 (Pubitemid 44431171)
9. Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995; 2:776-784
10. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 1996; 3:929-935
11. Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003; 27:750-757 (Pubitemid 37087744)
12. Jin GY, Lee JM, Lee YC, Han YM, Lim YS. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR 2004; 183:1013-1020
13. Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR 2005; 185:466-471
14. Tominaga J, Miyachi H, Ishibashi T, Takahashi S. Correlation between CT and pathological findings after radiofrequency ablation of rabbit lung: evaluation of therapeutic effective area [in Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 2004; 64:305-306
15. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14(9 Pt 2):S199-S202
16. Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR 1985; 144:261-265
17. Lee JM, Jin GY, Li CA, et al. Percutaneous radiofrequency thermal ablation of lung VX2 tumors in a rabbit model using a cooled tip-electrode: feasibility, safety, and effectiveness. Invest Radiol 2003; 38:129-139
18. Fietta AM, Morosini M, Passadore I. et al. Systemic inflammatory response and down-modulation of peripheral CD25+ Foxp3+ T regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancers. Hum Immunol 2009; 70:477-486
19. Takizawa T, Terashima M, Koike T, Akamatsu H, Kurita Y, Yokoyama A. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997; 113:248-252 (Pubitemid 27083896)
20. Stein DL, Haramati LB, Spindola-Franco H, Friedman J, Klapper PJ. Intrathoracic lymphadenopathy in hospitalized patients with pneumococcal pneumonia. Chest 2005; 127:1271-1275 (Pubitemid 46224290)
21. Glazer GM, Orringer MB, Gross BH, Quint LE. The mediastinum in non-small cell lung cancer: CT - surgical correlation. AJR 1984; 142:1101-1105 (Pubitemid 14112853)
22. Slanetz PJ, Truong M, Shepard JA, Trotman-Dickenson B, Drucker E, McLoud TC. Mediastinal lymphadenopathy and hazy mediastinal fat: new CT findings of congestive heart failure. AJR 1998; 171:1307-1309 (Pubitemid 28489418)
23. Bergin CJ, Park KJ. Lymph node enlargement in pulmonary arterial hypertension due to chronic thromboembolism. J Med Imaging Radiat Oncol 2008; 52:18-23
24. Attili AK, Kazerooni EA, Gross BH, Flaherty KR, Martinez FJ. Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolution. J Thorac Imaging 2006; 21:288-292
25. Souza CA, Müller NL, Lee KS, Johkoh T, Mitsuhiro H, Chong S. Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. AJR 2006; 186:995-999 (Pubitemid 46100198)
26. Sampson C, Hansell DM. The prevalence of enlarged mediastinal lymph nodes in asbestos-exposed individuals: a CT study. Clin Radiol 1992; 45:340-342
27. Ridolfi L, Cangini D, Galassi R, et al. Reversible, PET-positive, generalized lymphadenopathy and splenomegaly during high-dose interferon-alpha-2b adjuvant therapy for melanoma. J Immunother 2008; 31:675-678
28. Anonymous. Part IV: thorax. In: Greene FL, Page DL, Fleming ID, eds. AJCC cancer staging handbook. New York, NY: Springer-Verlag, 2002:91-241
29. Pombo F, Rodriguez E, Caruncho MV, Villalva C, Crespo C. CT attenuation values and enhancing characteristics of thoracoabdominal lymphomatous adenopathies. J Comput Assist Tomogr 1994; 18:59-62 (Pubitemid 24033857)
30. Ferreiros J, Gomez Leon N, Mata MI, Casanova R, Pedrosa CS, Cuevas A. Computed tomography in abdominal Castleman's disease. J Comput Assist Tomogr 1989; 13:433-436 (Pubitemid 19141763)
31. Pombo F, Rodriguez E, Mato J, Perez-Fontan J, Rivera E, Valvuena L. Patterns of contrast enhancement of tuberculous lymph nodes demonstrated by computed tomography. Clin Radiol 1992; 46:13-17
32. Magnusson A, Andersson T, Larsson B, Hagberg H, Sundstrom CH. Contrast enhancement of pathologic lymph nodes demonstrated by computed tomography. Acta Radiol 1989; 30:307-310 (Pubitemid 19152564)
33. Husband JE, Robinson L, Thomas G. Contrast enhancing lymph nodes in bladder cancer: a potential pitfall on CT. Clin Radiol 1992; 45:395-398
34. Shapeero LG, Blank N, Young SW. Contrast enhancement in mediastinal and cervical lymph nodes. J Comput Assist Tomogr 1983; 7:242-244 (Pubitemid 13121178)
35. Nakagawa T, Yamada M, Suzuki Y. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med 2008; 49:1053-1059 (Pubitemid 351948012)